Abstract:Objective: We have previously shown that lack of thioredoxin-interacting protein (TXNIP) protects against diabetes and glucotoxicity-induced beta-cell apoptosis. Because the role of TXNIP in lipotoxicity is unknown, the goal of the present study was to determine whether TXNIP expression is regulated by fatty acids and whether TXNIP deficiency also protects beta-cells against lipoapoptosis. RESARCH DESIGN AND METHODS: To determine the effects of fatty acids on beta-cell TXNIP expression, INS-1 cells and isolated islets were incubated with/without palmitate and rats underwent cyclic infusions of glucose and/or Intralipid prior to islet isolation and analysis by quantitative real-time RT-PCR and immunoblotting. Using primary wild-type and TXNIP-deficient islets, we then assessed the effects of palmitate on apoptosis (transferase-mediated dUTP nick-end labeling [TUNEL]), mitochondrial death pathway (cytochrome c release), and endoplasmic reticulum (ER) stress (binding protein [BiP], C/EBP homologous protein [CHOP]). Effects of TXNIP deficiency were also tested in the context of staurosporine (mitochondrial damage) or thapsigargin (ER stress). Results: Glucose elicited a dramatic increase in islet TXNIP expression both in vitro and in vivo, whereas fatty acids had no such effect and, when combined with glucose, even abolished the glucose effect. We also found that TXNIP deficiency does not effectively protect against palmitate or thapsigargin-induced beta-cell apoptosis, but specifically prevents staurosporine- or glucose-induced toxicity. Conclusions: Our results demonstrate that unlike glucose, fatty acids do not induce beta-cell expression of proapoptotic TXNIP. They further reveal that TXNIP deficiency specifically inhibits the mitochondrial death pathway underlying beta-cell glucotoxicity, whereas it has very few protective effects against ER stress-mediated lipoapoptosis.

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target

Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

Redox-Dependent And Independent Effects Of Thioredoxin Interacting Protein

Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

TXNIP Exacerbates the Senescence and Aging-Related Dysfunction of β Cells by Inducing Cell Cycle Arrest Through p38-p16/p21-CDK-Rb Pathway

Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death

Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways

Nitrosative/Oxidative Stress Conditions Regulate Thioredoxin-Interacting Protein (TXNIP) Expression and Thioredoxin-1 (TRX-1) Nuclear Localization

TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy

TXNIP Gene in Tumorigenesis and Metastasis

Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome

Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers

Thioredoxin-interacting Protein Links Oxidative Stress to Inflammasome Activation

Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death

Thioredoxin-interacting Protein Induced Α-Synuclein Accumulation Via Inhibition of Autophagic Flux: Implications for Parkinson's Disease.

The Role of TXNIP in Cancer: a Fine Balance Between Redox, Metabolic, and Immunological Tumor Control

Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention